ABC294640
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABC294640, covering 2025-04-27 to 2025-04-27. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Study of ABC294640 as Monotherapy in Patients With Advanced Hepatocellular Carcinoma [Phase 2]